Tebentafusp (IMCgp100), a first in class immune-mobilizing monoclonal T-cell receptors against cancer (ImmTAC) for HLA-A*02:01 positive uveal melanoma: Product review

Tebentafusp (IMCgp100, Kimmtrak) is a first-in-class Immune mobilizing monoclonal T-cell receptors against cancer (ImmTAC). ImmTAC are fusion proteins comprising an affinity-enhanced soluble T-cell receptor (TCR) against a specific peptide-HLA complex and an anti-CD3 single-chain variable fragment (...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jonathan E. Cohen, Inderjit Mehmi, Mordechai Avner, Justin Moyers, Omid Hamid
Format:	Artigo
Idioma:	Inglês
Publicat:	Taylor & Francis Group 2026-12-01
Col·lecció:	Human Vaccines & Immunotherapeutics
Matèries:	Uveal melanoma cancer immunotherapy Immune-mobilizing monoclonal T-cell receptors against cancer (ImmTAC) T-cell receptor (TCR) human leukocyte antigen (HLA)
Accés en línia:	https://www.tandfonline.com/doi/10.1080/21645515.2026.2675068
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!